These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22198250)
1. Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities. Eggers KM; Venge P Pathology; 2012 Feb; 44(2):129-38. PubMed ID: 22198250 [TBL] [Abstract][Full Text] [Related]
2. Use of cardiac biomarkers in neonatology. Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB Pediatr Res; 2012 Oct; 72(4):337-43. PubMed ID: 22797141 [TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331 [TBL] [Abstract][Full Text] [Related]
4. Cardiac biomarkers in the critically ill. Ventetuolo CE; Levy MM Crit Care Clin; 2011 Apr; 27(2):327-43. PubMed ID: 21440204 [TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study. Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population. de Lemos JA; deFilippi CR Coron Artery Dis; 2013 Dec; 24(8):705-9. PubMed ID: 24201087 [TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide detects cardiac abnormalities in mass screening. Takase H; Toriyama T; Sugiura T; Takahashi A; Sugiyama M; Ohashi M; Ueda R; Dohi Y Eur J Clin Invest; 2007 Apr; 37(4):257-62. PubMed ID: 17373960 [TBL] [Abstract][Full Text] [Related]
11. [Cardiac natriuretic peptides as markers of left ventricular dysfunction]. Omland T; Aakvaag A; Vik-Mo H Tidsskr Nor Laegeforen; 1997 Mar; 117(7):943-8. PubMed ID: 9103004 [TBL] [Abstract][Full Text] [Related]
12. Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting. Biccard BM; Devereaux PJ; Rodseth RN Anaesthesia; 2014 May; 69(5):484-93. PubMed ID: 24738805 [TBL] [Abstract][Full Text] [Related]
13. A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. Berridge BR; Pettit S; Walker DB; Jaffe AS; Schultze AE; Herman E; Reagan WJ; Lipshultz SE; Apple FS; York MJ Am Heart J; 2009 Jul; 158(1):21-9. PubMed ID: 19540388 [TBL] [Abstract][Full Text] [Related]
14. A window into your heart: taking cardiac troponin to the next level. Hallén J; Atar D Biomark Med; 2010 Dec; 4(6):889-94. PubMed ID: 21133709 [TBL] [Abstract][Full Text] [Related]
15. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. Mogelvang R; Goetze JP; Schnohr P; Lange P; Sogaard P; Rehfeld JF; Jensen JS J Am Coll Cardiol; 2007 Oct; 50(17):1694-701. PubMed ID: 17950153 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Mark PB; Stewart GA; Gansevoort RT; Petrie CJ; McDonagh TA; Dargie HJ; Rodger RS; Jardine AG Nephrol Dial Transplant; 2006 Feb; 21(2):402-10. PubMed ID: 16221702 [TBL] [Abstract][Full Text] [Related]